Chemoinformaics analysis of 11,12-Dimethoxydihydrokawain
Molecular Weight | 292.331 | nRot | 6 |
Heavy Atom Molecular Weight | 272.171 | nRig | 13 |
Exact Molecular Weight | 292.131 | nRing | 2 |
Solubility: LogS | -3.149 | nHRing | 1 |
Solubility: LogP | 2.753 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 5 | APOL | 44.0659 |
nHD | 0 | BPOL | 27.8761 |
QED | 0.754 |
Synth | 2.873 |
Natural Product Likeliness | 1.41 |
NR-PPAR-gamma | 0.073 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.989 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.494 |
MDCK | 0.0000462 |
BBB | 0.455 |
PPB | 0.928022 |
VDSS | 0.477 |
FU | 0.0412174 |
CYP1A2-inh | 0.438 |
CYP1A2-sub | 0.475 |
CYP2c19-inh | 0.928 |
CYP2c19-sub | 0.905 |
CYP2c9-inh | 0.775 |
CYP2c9-sub | 0.673 |
CYP2d6-inh | 0.281 |
CYP2d6-sub | 0.891 |
CYP3a4-inh | 0.868 |
CYP3a4-sub | 0.629 |
CL | 9.079 |
T12 | 0.857 |
hERG | 0.039 |
Ames | 0.022 |
ROA | 0.011 |
SkinSen | 0.955 |
Carcinogencity | 0.314 |
EI | 0.413 |
Respiratory | 0.798 |
NR-Aromatase | 0.291 |
Antiviral | Yes |
Prediction | 0.751497 |